Corrigendum to “Hybrid optimal descriptors as a tool to predict skin sensitization in accordance to OECD principles” (Hybrid optimal descriptors as a tool to predict skin sensitization in accordance to OECD principles (2017) 275 (57–66), (S037842741730125X), (10.1016/j.toxlet.2017.03.023));Hybrid optimal descriptors as a tool to predict skin sensitization in accordance to OECD principles

Toxicology Letters

Volumn 275, Issue , 2017, Pages 57-66

  Toropova, Alla P ^a   Toropov, Andrey A ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

CORAL software; Monte Carlo method; OECD principles; QSAR; Skin sensitization; SMILES

Indexed keywords

ANALYTIC METHOD; ARTICLE; CALIBRATION; CHEMICAL STRUCTURE; COMPARATIVE STUDY; CORAL SOFTWARE; LOCAL LYMPH NODE ASSAY; MATHEMATICAL MODEL; MONTE CARLO METHOD; ORGANISATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SIMPLIEFIED MOLECULAR INPUT LINE ENTRY SYSTEM; SKIN SENSITIZATION; SOFTWARE VALIDATION; TRAINING; ANIMAL TESTING ALTERNATIVE; CHEMISTRY; DERMATITIS, ALLERGIC CONTACT; MOLECULAR MODEL; PREDICTIVE VALUE; SOFTWARE; STANDARDS;

ORGANIC COMPOUND;

ANIMAL TESTING ALTERNATIVES; DERMATITIS, ALLERGIC CONTACT; MODELS, MOLECULAR; MOLECULAR STRUCTURE; MONTE CARLO METHOD; ORGANIC CHEMICALS; ORGANISATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT; PREDICTIVE VALUE OF TESTS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SOFTWARE;

EID: 85019024952     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2019.04.024     Document Type: Erratum

References (63)

1. Afantitis, A., Melagraki, G., Sarimveis, H., Koutentis, P.A., Markopoulos, J., Igglessi-Markopoulou, O., Development and evaluation of a QSPR model for the prediction of diamagnetic susceptibility. QSAR Comb. Sci. 27:4 (2008), 432–436.
2. Afantitis, A., Melagraki, G., Sarimveis, H., Koutentis, P.A., Igglessi-Markopoulou, O., Kollias, G., A combined LS-SVM & MLR QSAR workflow for predicting the inhibition of CXCR3 receptor by quinazolinone analogs. Mol. Divers 14:2 (2010), 225–235.
3. Afantitis, A., Melagraki, G., Koutentis, P.A., Sarimveis, H., Kollias, G., Ligand − based virtual screening procedure for the prediction and the identification of novel β-amyloid aggregation inhibitors using Kohonen maps and Counterpropagation Artificial Neural Networks. Eur. J. Med. Chem. 46:2 (2011), 497–508.
4. Alves, V.M., Muratov, E., Fourches, D., Strickland, J., Kleinstreuer, N., Andrade, C.H., Tropsha, A., Predicting chemically-induced skin reactions. Part I: QSAR models of skin sensitization and their application to identify potentially hazardous compounds. Toxicol. Appl. Pharm. 284 (2015), 262–272.
5. Barratt, M.D., Basketter, D.A., Roberts, D.W., Skin sensitization structure-activity relationships for phenyl benzoates. Toxicol. In Vitro 8:4 (1994), 823–826.
6. Cronin, M.T.D., Basketter, D.A., Multivariate QSAR analysis of a skin sensitization database. SAR QSAR Environ. Res. 2:3 (1994), 159–179.
7. Das, K.C., Gutman, I., Furtula, B., On spectral radius and energy of extended adjacency matrix of graphs. Appl. Math. Comput. 296 (2017), 116–123.
8. Dearden, J.C., Hewitt, M., Roberts, D.W., Enoch, S.J., Rowe, P.H., Przybylak, K.R., Vaughan-Williams, G.D., Smith, M.L., Pillai, G.G., Katritzky, A.R., Mechanism-Based QSAR modeling of skin sensitization. Chem. Res. Toxicol. 28:10 (2015), 1975–1986.
9. Dimitrov, S.D., Low, L.K., Patlewicz, G.Y., Kern, P.S., Dimitrova, G.D., Comber, M.H.I., Phillips, R.D., Niemela, J., Bailey, P.T., Mekenyan, O.G., Skin sensitization: modeling based on skin metabolism simulation and formation of protein conjugates. Int. J. Toxicol. 24:4 (2005), 189–204.
10. Duchowicz, P.R., Comelli, N.C., Ortiz, E.V., Castro, E.A., QSAR study for carcinogenicity in a large set of organic compounds. Curr. Drug Saf. 7:4 (2012), 282–288.
11. EC regulation, 1907/2006. Regulation (EC) No 1907/2006 of the European Parliament and the council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC.
12. EU Regulation, 1223/2009. Of The European Parliament And Of The Council of 30 November 2009 on cosmetic products. OJEU L 342/59-209.
13. Furtula, B., Gutman, I., Relation between second and third geometric-arithmetic indices of trees. J. Chemom. 25:2 (2011), 87–91.
14. Ghaedi, A., Predicting the cytotoxicity of ionic liquids using QSAR model based on SMILES optimal descriptors. J. Mol. Liq. 208 (2015), 269–279.
15. Gobbi, M., Beeg, M., Toropova, M.A., Toropov, A.A., Salmona, M., Monte Carlo method for predicting of cardiac toxicity: hERG blocker compounds. Toxicol. Lett., 250–251, 2016, 42.
16. Golla, S., Madihally, S., Robinson, R.L. Jr., Gasem, K.A.M., Quantitative structure–property relationship modeling of skin sensitization: a quantitative prediction. Toxicol. In Vitro 23 (2009), 454–465.
17. Grace, P., Roberts, D.W., Walker, J.D., QSARs for the skin sensitization potential of aldehydes and related compounds. QSAR Comb. Sci. 22:2 (2003), 196–203.
18. Grindon, C., Combes, R., Cronin, M.T.D., Roberts, D.W., Garrod, J.F., An integrated decision-tree testing strategy for skin sensitisation with respect to the requirements of the EU REACH legislation. Altern. Lab. Anim. 36:SUPPL. 1 (2008), 75–89.
19. Hoffmann, S., Saliner, A.G., Patlewicz, G., Eskes, C., Zuang, V., Worth, A.P., A feasibility study developing an integrated testing strategy assessing skin irritation potential of chemicals. Toxicol. Lett. 180:1 (2008), 9–20.
20. Jaworska, J., Harol, A., Kern, P.S., Gerberick, G.F., Integrating non-animal test information into an adaptive testing strategy − skin sensitization proof of concept case. ALTEX 28:3 (2011), 211–225.
21. Jaworska, J., Dancik, Y., Kern, P., Gerberick, F., Natsch, A., Bayesian integrated testing strategy to assess skin sensitization potency: from theory to practice. J. Appl. Toxicol. 33:11 (2013), 1353–1364.
22. Li, Q., Ding, X., Si, H., Gao, H., QSAR model based on SMILES of inhibitory rate of 2, 3-diarylpropenoic acids on AKR1C3. Chemometr. Intell. Lab. Syst. 139 (2014), 132–138.
23. Masand, V.H., Toropov, A.A., Toropova, A.P., Mahajan, D.T., QSAR models for anti-malarial activity of 4-aminoquinolines. Curr. Comput. Aided Drug Des. 10:1 (2014), 75–82.
24. Mehling, A., Eriksson, T., Eltze, T., Kolle, S., Ramirez, T., Teubner, W., van Ravenzwaay, B., Landsiedel, R., Non-animal test methods for predicting skin sensitization potentials. Arch. Toxicol. 86 (2012), 1273–1295.
25. Melagraki, G., Afantitis, A., A risk assessment tool for the virtual screening of metal oxide nanoparticles through enalos insiliconano platform. Curr. Top. Med. Chem. 15:18 (2015), 1827–1836.
26. Moore, C.A., Wilkinson, S.C., Blain, P.G., Dunn, M., Aust, G.A., Williams, F.M., Use of a human skin in vitro model to investigate the influence of ‘every-day' clothing and skin surface decontamination on the percutaneous penetration of organophosphates. Toxicol. Lett. 229:1 (2014), 257–264.
27. Moore, C.A., Wilkinson, S.C., Blain, P.G., Dunn, M., Aust, G.A., Williams, F.M., Percutaneous absorption and distribution of organophosphates (chlorpyrifos and dichlorvos) following dermal exposure and decontamination scenarios using in vitro human skin model. Toxicol. Lett. 229:1 (2014), 66–72.
28. Nandy, A., Kar, S., Roy, K., Development and validation of regression-based QSAR models for quantification of contributions of molecular fragments to skin sensitization potency of diverse organic chemicals. SAR QSAR Environ. Res. 24:12 (2013), 1009–1023.
29. Natsch, A., Gfeller, H., LC-MS–Based characterization of the peptide reactivity of chemicals to improve the in vitro prediction of the skin sensitization potential. Toxicol. Sci. 106:2 (2008), 464–478.
30. Nukada, Y., Ashikaga, T., Miyazawa, M., Hirota, M., Sakaguchi, H., Sasa, H., Nishiyama, N., Prediction of skin sensitization potency of chemicals by human Cell Line Activation Test (h-CLAT) and an attempt at classifying skin sensitization potency. Toxicol. In Vitro 26 (2012), 1150–1160.
31. OECD, 1992. OECD Guideline for the testing of chemicals 406: Skin sensitization, adopted: 17 July 1992. http://www.oecd-ilibrary.org/environment/oecd-guidelines-for-the-testing-of-chemicals-section-4-health-effects_20745788.
32. OECD, 2007. (Organization for Economic Co-operation and Development). Guidance Document on The Validation of (Quantitative) Structure-Activity Relationship [(Q)SAR] Models No. 69.
33. OECD, 2010. OECD Guideline for the testing of chemicals 429: Skin sensitization: local lymph node assay revised. 2010. http://www.oecd-ilibrary.org/environment/oecd-guidelines-for-the-testing-of-chemicals-section-4-health-effects_20745788.
34. OECD, 2012. The adverse outcome pathway for skin sensitisation initiated by covalent binding to proteins. OECD environment, health and safety publications: No.168; ENV/JM/MONO(2012)10.
35. OECD, 2015. Performance standards for assessment of proposed similar or modified in vitro skin sensitization ARE–NRF2 Luciferase test method series on testing and assessment No. 213; ENV/JM/MONO (2015) 6.
36. Ojha, P.K., Roy, K., Comparative QSARs for antimalarial endochins: importance of descriptor-thinning and noise reduction prior to feature selection. Chemometr. Intell. Lab. Syst. 109:2 (2011), 146–161.
37. Promkatkaew, M., Gleeson, D., Hannongbua, S., Gleeson, M.P., Skin sensitization prediction using quantum chemical calculations: a theoretical model for the SNAr domain. Chem. Res. Toxicol. 27:1 (2014), 51–60.
38. Ren, Y., Liu, H., Xue, C., Yao, X., Liu, M., Fan, B., Classification study of skin sensitizers based on support vector machine and linear discriminant analysis. Anal. Chim. Acta 572:2 (2006), 272–282.
39. Roberts, D.W., Patlewicz, G.Y., Updating the skin sensitization in vitro data assessment paradigm in 2009 − a chemistry and QSAR perspective. J. Appl. Toxicol. 30:3 (2010), 286–288.
40. Roberts, D.W., Aptula, A.O., Patlewicz, G., Mechanistic applicability domains for non-animal based prediction of toxicological endpoints. QSAR analysis of the Schiff base applicability domain for skin sensitization. Chem. Res. Toxicol. 19:9 (2006), 1228–1233.
41. Scotti, L., Ishiki, H., Ferreira, M.J.P., Francisco, J.B.M. Jr., De, P., Emerenciano, V., Silva, M.S., Scotti, M.T., In silico methods applied in food chemistry: a short review with bitter and mutagenic compounds. Lett. Drug Des. Discov. 9:5 (2012), 527–534.
42. Scotti, L., Lima, E.O., da Silva, M.S., Ishiki, H., Lima, I.O., Pereira, F.O., Mendonça, F.J.B. Jr., Scotti, M.T., Docking and PLS studies on a set of thiophenes RNA polymerase inhibitors against Staphylococcus aureus. Curr. Top. Med. Chem. 14:1 (2014), 64–80.
43. Speck-Planche, A., Kleandrova, V.V., Luan, F., Ds Cordeiro, M.N., Computational modeling in nanomedicine: prediction of multiple antibacterial profiles of nanoparticles using a quantitative structure-activity relationship perturbation model. Nanomedicine 10:2 (2015), 193–204.
44. Toropov, A.A., Toropova, A.P., QSAR modeling of toxicity on optimization of correlation weights of Morgan extended connectivity. J. Mol. Struc. Theochem. 578 (2002), 129–134.
45. Toropov, A.A., Toropova, A.P., Modeling of acyclic carbonyl compounds normal boiling points by correlation weighting of nearest neighboring codes. J. Mol. Struct. Theochem. 581 (2002), 11–15.
46. Toropov, A.A., Toropova, A.P., QSPR modeling of alkanes properties based on graph of atomic orbitals. J. Mol. Struct. Theochem. 637 (2003), 1–10.
47. Toropov, A.A., Toropova, A.P., Benfenati, E., Gini, G., Leszczynska, D., Leszczynski, J., CORAL: QSPR model of water solubility based on local and global SMILES attributes. Chemosphere 90:2 (2013), 877–880.
48. Toropov, A.A., Toropova, A.P., Puzyn, T., Benfenati, E., Gini, G., Leszczynska, D., Leszczynski, J., QSAR as a random event: modeling of nanoparticles uptake in PaCa2 cancer cells. Chemosphere 92:1 (2013), 31–37.
49. Toropova, A.P., Toropov, A.A., Veselinović, J.B., Veselinović, A.M., QSAR as a random event: a case of NOAEL. Environ. Sci. Pollut. Res. 22:11 (2014), 8264–8271.
50. Toropova, M.A., Toropov, A.A., Raška, I., Rašková, M., Searching therapeutic agents for treatment of Alzheimer disease using the Monte Carlo method. Comput. Biol. Med. 64 (2015), 148–154.
51. Toropova, A.P., Schultz, T.W., Toropov, A.A., Building up a QSAR model for toxicity toward Tetrahymena pyriformis by the Monte Carlo method: a case of benzene derivatives. Environ. Toxicol. Pharm. 42 (2016), 135–145.
52. Torrens, F., Castellano, G., QSPR prediction of retention times of phenylurea herbicides by biological plastic evolution. Curr. Drug Saf. 7:4 (2012), 262–268.
53. Torrens, F., Castellano, G., QSPR prediction of chromatographic retention times of pesticides: partition and fractal indices. J. Environ. Sci. Health B 49:6 (2014), 400–407.
54. Vandebriel, R.J., Loveren, H.V., Non-animal sensitization testing: state-of-the-art. Crit. Rev. Toxicol. 40:5 (2010), 389–404.
55. van der Jagt, K., Munn, S., Torslov, J., de Bruijn, J., Alternative Approaches can Reduce the Use of Test Animals Under REACH. Addendum To: Assessment of Additional Testing Needs Under REACH Effects of (Q)SARS, Risk Based Testing and Voluntary Industry Initiatives. IHCP Report EUR 21405 EN., 2004.
56. Verheyen, G.R., Braeken, E., Van Deun, K., Van Miert, S., Evaluation of existing (Q)SAR models for skin and eye irritation and corrosion to use for REACH registration. Toxicol. Lett. 265 (2017), 47–52.
57. Veselinović, A.M., Veselinović, J.B., Toropov, A.A., Toropova, A.P., Nikolić, G.M., Qsar models for the reactivation of sarin inhibited acetylcholinesterase by quaternary pyridinium oximes based on Monte Carlo method. Curr. Comput. Aid Drug Des. 10:3 (2014), 266–273.
58. Veselinović, A.M., Veselinović, J.B., Toropov, A.A., Toropova, A.P., Nikolić, G.M., In silico prediction of the β-cyclodextrin complexation based on Monte Carlo method. Int. J. Pharm. 495:1 (2015), 404–409.
59. Veselinović, A.M., Veselinović, J.B., Živković, J.V., Nikolić, G.M., Application of smiles notation based optimal descriptors in drug discovery and design. Curr. Top. Med. Chem. 15:18 (2015), 1768–1779.
60. Veselinović J, J.B., Nikolić, G.M., Trutić, N.V., Živković, J.V., Veselinović, A.M., Monte Carlo QSAR models for predicting organophosphate inhibition of acetylcholinesterase. SAR QSAR Environ. Res. 26:6 (2015), 449–460.
61. Worachartcheewan, A., Mandi, P., Prachayasittikul, V., Toropova, A.P., Toropov, A.A., Nantasenamat, C., Large-scale QSAR study of aromatase inhibitors using SMILES-based descriptors. Chemometr. Intell. Lab. Syst. 138 (2014), 120–126.
62. Worachartcheewan, A., Prachayasittikul, V., Toropova, A.P., Toropov, A.A., Nantasenamat, C., Large-scale structure-activity relationship study of hepatitis C virus NS5 B polymerase inhibition using SMILES-based descriptors. Mol. Divers 19:4 (2015), 955–964.
63. Zhang, S., Golbraikh, A., Oloff, S., Kohn, H., Tropsha, A., A novel Automated Lazy Learning QSAR (ALL-QSAR) approach: method development, applications, and virtual screening of chemical databases using validated ALL-QSAR models. J. Chem. Inf. Model. 46:5 (2006), 1984–1995.